Coinciding with World Immunization Week, VBC proudly announces the official launch of 𝐖𝐞𝐮𝐩𝐡𝐨𝐫𝐢𝐚 𝐏𝐂𝐕-𝟏𝟑 (Pneumococcal Conjugate Vaccine-13), a critical advancement in public health and vaccine localization.
To mark this achievement, VBC hosted an inspiring launch event and panel discussion dedicated to the future of immunization and a shared vision for community well-being.
The introduction of 𝐖𝐞𝐮𝐩𝐡𝐨𝐫𝐢𝐚 𝐏𝐂𝐕-𝟏𝟑 represents VBC’s commitment to accessible healthcare, and localized manufacturing excellence.
Together, we can transform 𝐄𝐠𝐲𝐩𝐭’𝐬 𝐟𝐮𝐭𝐮𝐫𝐞 in pneumococcal vaccination landscape and protect next generation.
